IQWiG Backs Novartis’ Jetrea, Drops Almirall’s Constella On Same Day
This article was originally published in The Pink Sheet Daily
Executive Summary
Germany’s IQWiG has backed Novartis’ Jetrea for VMT, albeit with restricted indication, but knocked back Almirall’s Constella, citing study irrelevance.